In ‘A Conversation on Courage,’ Lord Cameron and Morgan Stanley’s Andy Saperstein discussed philanthropy as a…
Category: News
Tagworks Pharmaceuticals inicia la tercera dosis del ensayo clínico de fase 1 de TGW101
–Tagworks Pharmaceuticals anuncia el inicio de la tercera dosis del ensayo clínico de fase 1 de…
Rooted Owl Announces Clinical Study Results on Hemp-Based Calming Oil for Dogs
NEW YORK, Sept. 10, 2025 /PRNewswire/ — Rooted Owl has released results from a clinical study…
Avidity Biosciences Announces Proposed Public Offering of Common Stock
SAN DIEGO, Sept. 10, 2025 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA),a biopharmaceutical company committed to…
Sharps Technology and Pudgy Penguins Announce Strategic Partnership
NEW YORK, Sept. 10, 2025 /PRNewswire/ — Sharps Technology (“Sharps Technology” or the “Company”) (NASDAQ: STSS),…
GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors – 2nd Annual Healthcare Forum
MENLO PARK, Calif., Sept. 10, 2025 /PRNewswire/ — GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose…
Health Catalyst Appoints Ben Albert to the Role of President and COO
Albert Appointed to Drive Health Catalyst Forward in Its Next Chapter of Enabling Measurable Healthcare Improvement…
Prinses Máxima Center for Pediatric Oncology met en œuvre Callisto™ de Volta Labs pour rationaliser les flux de travail en génomique clinique
BOSTON, 10 septembre 2025 /PRNewswire/ — Volta Labs a annoncé aujourd’hui que le Prinses Máxima Center…
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2026
STATESVILLE, N.C., Sept. 10, 2025 /PRNewswire/ — PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced…
Prinses Máxima Center for Pediatric Oncology implementiert Callisto™ von Volta Labs zur Rationalisierung klinischer Genomik-Workflows
BOSTON, 10. September 2025 /PRNewswire/ — Volta Labs gab heute bekannt, dass das Prinses Máxima Center…